Glycoprotein IIb/IIIa Inhibitors Use and Outcome after Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction

por Howard, J. P., Jones, D. A., Gallagher, S., Rathod, K., Antoniou, S., Wright, P., Knight, C., Mathur, A., Weerackody, R., Wragg, A.
Publicado 2014

Eptifibatide is associated with significant cost savings and similar clinical outcomes to abciximab when used during primary percutaneous coronary intervention for ST-elevation myo...

por Rathod, KS, Antoniou, S, Avari, P, Ding, N, Wright, P, Knight, C, Jain, AK, Mathur, A, Smith, EJ, Weerackody, R, Wragg, A, Jones, DA
Publicado 2017